These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32194366)

  • 21. Altered ventral striatal activation during reward and punishment processing in premanifest Huntington's disease: a functional magnetic resonance study.
    Enzi B; Edel MA; Lissek S; Peters S; Hoffmann R; Nicolas V; Tegenthoff M; Juckel G; Saft C
    Exp Neurol; 2012 May; 235(1):256-64. PubMed ID: 22366326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of serum uric acid levels with the progression of Parkinson's disease in Chinese patients.
    Sun CC; Luo FF; Wei L; Lei M; Li GF; Liu ZL; LE WD; Xu PY
    Chin Med J (Engl); 2012 Feb; 125(4):583-7. PubMed ID: 22490478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.
    Wolf RC; Vasic N; Schönfeldt-Lecuona C; Landwehrmeyer GB; Ecker D
    Brain; 2007 Nov; 130(Pt 11):2845-57. PubMed ID: 17855375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired Isometric Force Matching in Upper and Lower Limbs Revealed by Quantitative Motor Assessments in Huntington's Disease.
    Medzech S; Sass C; Bohlen S; Lange HW; Koch R; Schubert R; Ringelstein EB; Reilmann R
    J Huntingtons Dis; 2019; 8(4):483-492. PubMed ID: 31450507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal metabolite changes in Huntington's disease during disease onset.
    van den Bogaard SJ; Dumas EM; Teeuwisse WM; Kan HE; Webb A; van Buchem MA; Roos RA; van der Grond J
    J Huntingtons Dis; 2014; 3(4):377-86. PubMed ID: 25575959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender-specific effect of uric acid on resting-state functional networks in de novo Parkinson's disease.
    Lee Y; Park YH; Lee JJ; Sohn YH; Lee JM; Lee PH
    Parkinsonism Relat Disord; 2018 Jul; 52():49-54. PubMed ID: 29606606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
    Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The validity, stability, and utility of measuring uric acid in saliva.
    Riis JL; Bryce CI; Matin MJ; Stebbins JL; Kornienko O; Huisstede LV; Granger DA
    Biomark Med; 2018 Jun; 12(6):583-596. PubMed ID: 29873515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary uric acid as a noninvasive biomarker for monitoring the efficacy of urate-lowering therapy in a patient with chronic gouty arthropathy.
    Zhao J; Huang Y
    Clin Chim Acta; 2015 Oct; 450():115-20. PubMed ID: 26276048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI.
    Chen L; Hua J; Ross CA; Cai S; van Zijl PCM; Li X
    J Neurosci Res; 2019 Apr; 97(4):467-479. PubMed ID: 30489648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.
    Díez-Planelles C; Sánchez-Lozano P; Crespo MC; Gil-Zamorano J; Ribacoba R; González N; Suárez E; Martínez-Descals A; Martínez-Camblor P; Álvarez V; Martín-Hernández R; Huerta-Ruíz I; González-García I; Cosgaya JM; Visioli F; Dávalos A; Iglesias-Gutiérrez E; Tomás-Zapico C
    Pharmacol Res; 2016 Jun; 108():102-110. PubMed ID: 27155059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Objective assessment of gait and posture in premanifest and manifest Huntington disease - A multi-center study.
    Beckmann H; Bohlen S; Saft C; Hoffmann R; Gerss J; Muratori L; Ringelstein EB; Landwehrmeyer GB; Reilmann R
    Gait Posture; 2018 May; 62():451-457. PubMed ID: 29660633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
    van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
    J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saliva as an alternative non-invasive biomarker for the estimation of uric acid levels during pregnancy: A longitudinal study.
    Deepashree PG; Madhushankari GS; Nandini DB; Priya NK; Ashwini R; Shruthy R
    J Oral Maxillofac Pathol; 2021; 25(3):457-462. PubMed ID: 35281142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of stimulus-related variables on mental states recognition in Huntington's disease.
    Belardinelli MO; Huenefeldt T; Maffi S; Squitieri F; Migliore S
    Int J Neurosci; 2019 Jun; 129(6):563-572. PubMed ID: 30481084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual Object Perception in Premanifest and Early Manifest Huntington's Disease.
    Coppen EM; Jacobs M; van der Zwaan KF; Middelkoop HAM; Roos RAC
    Arch Clin Neuropsychol; 2019 Nov; 34(8):1320-1328. PubMed ID: 30796801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of plasma-derived miRNAs mimic differences in Huntington's disease brain.
    Hoss AG; Lagomarsino VN; Frank S; Hadzi TC; Myers RH; Latourelle JC
    Mov Disord; 2015 Dec; 30(14):1961-4. PubMed ID: 26573701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
    Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
    Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN).
    Hawton A; Green C; Goodwin E; Harrower T
    Eur J Health Econ; 2019 Dec; 20(9):1335-1347. PubMed ID: 31410669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.